Chapter 1. Introduction to Green Chemistry, Organic Synthesis and Pharmaceuticals
- Dr. Peter J. Dunn2,3,
- Dr. Andrew S. Wells4,
- Dr. Michael T. Williams5
Published Online: 19 MAR 2010
DOI: 10.1002/9783527629688.ch1
Copyright © 2010 Wiley-VCH Verlag GmbH & Co. KGaA
Book Title
Green Chemistry in the Pharmaceutical Industry
Additional Information
How to Cite
Sheldon, R. (2010) Introduction to Green Chemistry, Organic Synthesis and Pharmaceuticals, in Green Chemistry in the Pharmaceutical Industry (eds P. J. Dunn, A. S. Wells and M. T. Williams), Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany. doi: 10.1002/9783527629688.ch1
Editor Information
- 2
Pfizer Green Chemistry Lead, Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom
- 3
Pfizer Global Research and Development, Ramsgate Road, Sandwich, Kent, CT13 9NJ, UK
- 4
Astra Zeneca, Process Research & Development, Bakewell Road, Loughborough, LE11 5RH, United Kingdom
- 5
CMC Consultant, 133, London Road, Deal, Kent, CT14 9TY, United Kingdom
Publication History
- Published Online: 19 MAR 2010
- Published Print: 10 MAR 2010
ISBN Information
Print ISBN: 9783527324187
Online ISBN: 9783527629688
- Summary
- Chapter
- References
Keywords:
- history of organic chemistry;
- Taxol;
- E factor;
- atom economy;
- catalytic methodologies;
- biocatalysis;
- benign by design;
- twelve principles;
- solvent reduction
Summary
This chapter contains sections titled:
The Development of Organic Synthesis
The Environmental Factor
The Role of Catalysis
Green Chemistry: Benign by Design
Ibuprofen Manufacture
The Question of Solvents: Alternative Reaction Media
Biocatalysis: Green Chemistry Meets White Biotechnology
Conclusions and Prospects
References